<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">06492</article-id><article-id pub-id-type="doi">10.7554/eLife.06492</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Evolutionary Biology</subject></subj-group></article-categories><title-group><article-title>Reverse evolution leads to genotypic incompatibility despite functional and active-site convergence</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-27775"><name><surname>Kaltenbach</surname><given-names>Miriam</given-names></name><aff><institution content-type="dept">Michael Smith Laboratories</institution>, <institution>University of British Columbia</institution>, <addr-line><named-content content-type="city">Vancouver</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27776"><name><surname>Jackson</surname><given-names>Colin J</given-names></name><aff><institution content-type="dept">Research School of Chemistry</institution>, <institution>Australian National University</institution>, <addr-line><named-content content-type="city">Canberra</named-content></addr-line>, <country>Australia</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27777"><name><surname>Campbell</surname><given-names>Eleanor C</given-names></name><aff><institution content-type="dept">Research School of Chemistry</institution>, <institution>Australian National University</institution>, <addr-line><named-content content-type="city">Canberra</named-content></addr-line>, <country>Australia</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13545"><name><surname>Hollfelder</surname><given-names>Florian</given-names></name><aff><institution content-type="dept">Department of Biochemistry</institution>, <institution>University of Cambridge</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-23954"><name><surname>Tokuriki</surname><given-names>Nobuhiko</given-names></name><aff><institution content-type="dept">Michael Smith Laboratories</institution>, <institution>University of British Columbia</institution>, <addr-line><named-content content-type="city">Vancouver</named-content></addr-line>, <country>Canada</country><email>tokuriki@msl.ubc.ca</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1127"><name><surname>Laub</surname><given-names>Michael</given-names></name><role>Reviewing editor</role><aff><institution>Massachusetts Institute of Technology</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>14</day><month>08</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e06492</elocation-id><supplementary-material><ext-link xlink:href="elife-06492-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>15</day><month>01</month><year>2015</year></date><date date-type="accepted"><day>13</day><month>08</month><year>2015</year></date></history><permissions><copyright-statement>Â© 2015, Kaltenbach et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Kaltenbach et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Understanding to which extent enzyme evolution is reversible can shed light on the fundamental relationship between protein sequence, structure, and function. Here, we perform an experimental test of evolutionary reversibility using directed evolution from a phosphotriesterase to an arylesterase, and back, and examine the underlying molecular basis. We find that wild-type phosphotriesterase function could be restored (&amp;gt;10<sup>4</sup>-fold activity increase), but via an alternative set of mutations. The enzyme active site converged towards its original state, indicating evolutionary constraints imposed by catalytic requirements. We reveal that extensive epistasis prevents reversions and necessitates fixation of new mutations, leading to a functionally identical sequence in which many amino acid exchanges between the two sequences are not tolerated, implying sequence incompatibility. Therefore, the evolution was phenotypically reversible, but genotypically irreversible. Our study illustrates that the enzyme's adaptive landscape is highly rugged, and different functional sequences may constitute separate fitness peaks.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>